"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."

During the past decade, Aspirus Heart & Vascular Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspirus Heart & Vascular Institute" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "HealthCore-NERI" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "CVRx, Inc." with 1 trials sponsored and "CeloNova BioSciences, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Heart & Vascular Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Aspirus Heart & Vascular Institute" are "Coronary Artery Disease" (2 trials), "Artery Diseases, Peripheral" (1 trials), "Atherosclerosis" (1 trials), "Atrial Fibrillation" (1 trials) and "Cardiac Surgery" (1 trials). Many other conditions were trialed in "Aspirus Heart & Vascular Institute" in a lesser frequency.

Most popular intervention types in "Aspirus Heart & Vascular Institute" are "Device" (6 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMPLATZER Cardiac Plug" (1 trials), "BAROSTIM NEO® System" (1 trials), "COBRA PzF" (1 trials), "PROMUS Element Plus" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Heart & Vascular Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Aspirus Heart & Vascular Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Aspirus Heart & Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Heart & Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".